Investigating the Source of HIV-1 Viremia in Patients on Antiretroviral Therapy Through Intensification With MK-0518 [raltegravir]
Phase of Trial: Phase II/III
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Oct 2016 Status changed from recruiting to completed.
- 03 Mar 2008 New trial record.